<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Rapid cycling bipolar disorder: Epidemiology, pathogenesis, clinical features, and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Rapid cycling bipolar disorder: Epidemiology, pathogenesis, clinical features, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Rapid cycling bipolar disorder: Epidemiology, pathogenesis, clinical features, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ralph Kupka, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Keck, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Solomon, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H5068102"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Bipolar disorder is characterized by mood episodes that are nearly always recurrent [<a href="#rid1">1,2</a>]. Patients who experience at least four episodes during a 12-month period are classified in the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) as “rapid cycling” [<a href="#rid2">2</a>].</p><p>The term was first used in 1974 to describe bipolar patients who were unresponsive to <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">lithium</a> [<a href="#rid3">3</a>]. However, it is now clear that any form of pharmacotherapy (including lithium) is typically less effective for rapid cycling patients than for non-rapid cycling patients [<a href="#rid4">4</a>].</p><p>This topic reviews the epidemiology, pathogenesis, clinical features, and diagnosis of rapid cycling in patients with bipolar disorder. Treatment of rapid cycling is discussed separately, as is the diagnosis and general treatment of bipolar disorder:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16890.html" rel="external">"Rapid cycling bipolar disorder in adults: Treatment of major depression"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16847.html" rel="external">"Rapid cycling bipolar disorder in adults: Treatment of mania and hypomania"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/678.html" rel="external">"Bipolar disorder in adults: Epidemiology and pathogenesis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/679.html" rel="external">"Bipolar mania and hypomania in adults: Choosing pharmacotherapy"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15267.html" rel="external">"Bipolar major depression in adults: Choosing treatment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/680.html" rel="external">"Bipolar disorder in adults: Choosing maintenance treatment"</a>.)</p><p></p><p class="headingAnchor" id="H87172591"><span class="h1">DEFINITIONS</span><span class="headingEndMark"> — </span>Bipolar disorder is characterized by episodes of mania  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>), hypomania  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>), and major depression  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>) [<a href="#rid2">2</a>]. The major subtypes of bipolar disorder include bipolar I and bipolar II. Patients with bipolar I disorder experience manic episodes, and nearly always experience major depressive and hypomanic episodes. Bipolar II disorder is marked by at least one hypomanic episode, at least one major depressive episode, and the absence of manic episodes. Most patients suffer from multiple mood episodes over their lifetime. Patients who experience at least four episodes during a 12-month period are classified as “rapid cycling.” Additional information about the clinical features and diagnosis of bipolar disorder is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14642.html" rel="external">"Bipolar disorder in adults: Clinical features"</a> and  <a class="medical medical_review" href="/z/d/html/86602.html" rel="external">"Bipolar disorder in adults: Assessment and diagnosis", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H5068109"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H894696448"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>The prevalence of rapid cycling bipolar disorder is based upon community surveys and clinical studies from academic medical centers.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>General population</strong> – A cross-national community study (n &gt;54,000 individuals in 10 countries) found that the estimated 12-month prevalence of rapid cycling bipolar disorder in the general population was 0.3 percent [<a href="#rid5">5</a>]. The prevalence ranged from 0.0 percent in Bulgaria, India, and Japan to 0.7 percent in the United States.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with bipolar disorder</strong> – The estimated prevalence of rapid cycling among bipolar patients differs across studies and is reported to be higher among individuals who are ascertained in studies of the general population than in studies conducted in clinical settings; this discrepancy probably reflects methodologic differences between population studies (which may include milder mood episodes) and clinical studies:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Community settings</strong> – A cross-national community study found that among all bipolar patients, the one-year prevalence of rapid cycling was approximately 30 percent [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical settings</strong> – Studies in clinical settings indicate that the one-year prevalence of rapid cycling in patients with bipolar disorder is approximately 10 to 20 percent:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A review of 12 clinical studies (n &gt;8000 bipolar patients) found that the mean one-year prevalence of rapid cycling was 18 percent, and the lifetime prevalence was 31 percent [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In a subsequent, prospective, multinational study of 726 patients who presented with bipolar major depression, 22 percent met DSM-5-TR criteria for rapid cycling during the past year [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Retrospective studies of bipolar patients (n &gt;2600 and n &gt;1600) found that the one-year prevalence of rapid cycling was 8 and 10 percent [<a href="#rid8">8,9</a>].</p><p></p><p class="headingAnchor" id="H1412771"><span class="h2">Sociodemographic correlates</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Age</strong> – Age of onset of bipolar disorder may be younger in patients who develop rapid cycling bipolar disorder, compared with non-rapid cycling bipolar disorder [<a href="#rid8">8</a>]. A cross-national community study found that onset of bipolar disorder occurred at a younger age among rapid cycling individuals compared with non-rapid cycling individuals (mean age 17 versus 20 years) [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sex</strong> – It is not clear if rapid cycling occurs equally in females and males, or more often in females:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Based upon a cross-national community study, rapid cycling appears to equally affect females and males in the general population [<a href="#rid5">5</a>]. This is consistent with the finding that the lifetime prevalence of bipolar disorder in both sexes is approximately equal. (See  <a class="medical medical_review" href="/z/d/html/678.html" rel="external">"Bipolar disorder in adults: Epidemiology and pathogenesis", section on 'Epidemiology'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>However, studies in clinical settings indicate that rapid cycling is associated with female gender. A meta-analysis of 16 clinical studies with 3394 bipolar patients (including 929 with rapid cycling) found a slightly larger prevalence of rapid cycling in female bipolar patients than male patients [<a href="#rid10">10</a>], as did subsequent studies [<a href="#rid8">8,11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other factors</strong> – Neglect during childhood and parental divorce both appear to be more common in rapid cycling individuals in the general population compared to individuals with non-rapid cycling bipolar disorder [<a href="#rid5">5</a>].</p><p></p><p class="headingAnchor" id="H190200559"><span class="h2">Functional impairment</span><span class="headingEndMark"> — </span>Psychosocial functioning is generally more impaired in rapid cycling than non-rapid cycling bipolar disorder [<a href="#rid8">8,12-15</a>]. A cross-national community study found that during bipolar depressive episodes in the past year, severe role impairment occurred in more rapid cycling patients than non-rapid cycling patients (87 versus 67 percent) [<a href="#rid5">5</a>]. During manic/hypomanic episodes, rapid cycling patients were unable to function for more days than non-rapid cycling patients (51 versus 21 days).</p><p></p><p>Functional impairment in patients with rapid cycling may be due to an increased number of mood episodes. In addition, a shorter time in remission between mood episodes can hinder functional recovery.</p><p class="headingAnchor" id="H190200718"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis of rapid cycling bipolar disorder is not known.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetics</strong> – Although there is considerable evidence for the genetic transmission of bipolar disorder [<a href="#rid1">1,16,17</a>], support for the heritability of a rapid cycling course is lacking. A meta-analysis of four family history studies (693 bipolar patients, including 146 with rapid cycling) found that rapid cycling did not aggregate within families [<a href="#rid10">10</a>]; a subsequent study (305 bipolar patients, including 46 with rapid cycling) also failed to find evidence that rapid cycling is a familial trait [<a href="#rid18">18</a>]. In addition, linkage studies have not consistently identified any specific genes associated with rapid cycling [<a href="#rid19">19-24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Endocrinopathies</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diabetes</strong> – Diabetes may possibly be involved in the pathogenesis of some cases of rapid cycling. A prospective study of bipolar patients with type 2 diabetes (n = 26) and euglycemic bipolar patients (n = 56) found that rapid cycling occurred in more patients with type 2 diabetes than euglycemic patients (39 versus 18 percent) [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hypothyroidism</strong> – Hypothyroidism does not appear to cause rapid cycling bipolar disorder; a meta-analysis of six studies (275 bipolar patients, including 121 with rapid cycling) found that hypothyroidism was present in a comparable number of rapid cycling and non-rapid cycling patients [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurobiologic correlates</strong> – Although biomarkers specific for rapid cycling bipolar disorder have not been established, different biologic correlates of rapid cycling bipolar disorder have been identified [<a href="#rid26">26</a>]; however, it is not clear whether these findings represent etiologic causes or sequelae of the disorder because the studies investigated patients who already met criteria for rapid cycling.</p><p></p><p class="bulletIndent1">Neuroimaging studies have found several correlates of rapid cycling. As an example, magnetic resonance imaging (MRI) studies have found that the ventral prefrontal cortex is significantly smaller in rapid cycling patients than in non-rapid cycling patients and healthy controls [<a href="#rid27">27,28</a>]. Other gray matter structures that are significantly smaller in rapid cycling patients compared with healthy controls include the medial orbital prefrontal cortex, anterior cingulate, insula, and parahippocampus [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psychosocial factors</strong> – A history of childhood maltreatment is associated with rapid cycling. As an example, a meta-analysis of eight studies (n &gt;3000 patients with bipolar disorder) found that the risk of rapid cycling was greater in bipolar patients with a history of childhood maltreatment (physical, sexual, or emotional abuse; neglect; or family conflict), compared with patients without a history of maltreatment (odds ratio 1.9, 95% CI 1.5-2.5) [<a href="#rid29">29</a>].</p><p></p><p class="headingAnchor" id="H190200740"><span class="h2">Antidepressants</span><span class="headingEndMark"> — </span>Although some authorities think that antidepressants (particularly tricyclics) can trigger and prolong rapid cycling bipolar disorder [<a href="#rid30">30,31</a>], this is not established and remains a point of contention [<a href="#rid10">10,32-36</a>], due to the low quality, limited evidence that is available [<a href="#rid37">37</a>]. A few prospective observational studies have found an association between antidepressants and rapid cycling; as an example, the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study followed 1191 bipolar patients for up to one year and found that rapid cycling occurred nearly four times more often in patients who received antidepressants compared with patients who did not [<a href="#rid38">38</a>]. In addition, a prospective study compared 159 rapid cycling patients with 567 non-rapid cycling patients and found that treatment with antidepressants was associated with greater irritability and treatment resistance in rapid cycling patients [<a href="#rid7">7</a>]. By contrast, other studies refute the association between antidepressants and the emergence of rapid cycling; in one study that followed 345 bipolar patients for a mean of 14 years, antidepressants were not associated with onset of rapid cycling and resolution of rapid cycling was not associated with discontinuation of antidepressants [<a href="#rid14">14</a>]. Contrary to the idea that antidepressants precipitate rapid cycling, it has been suggested that it is frequent episodes of major depression that are associated with rapid cycling (as well as administration of an antidepressant) [<a href="#rid39">39</a>].</p><p>Additional indirect evidence suggests that adjunctive antidepressants may not cause or exacerbate rapid cycling and are safe to use in many patients with rapid cycling [<a href="#rid34">34</a>]. Both short-term (eg, ≤6 months) [<a href="#rid40">40,41</a>] and long-term (&gt;6 months) [<a href="#rid42">42,43</a>] randomized trials have found that adjunctive antidepressants do not increase rates of switching from major depression to mania/hypomania. In so far as patients are not switching from one pole to the other, they may not be at increased risk of rapid cycling. (See  <a class="medical medical_review" href="/z/d/html/14655.html" rel="external">"Bipolar major depression in adults: Efficacy and adverse effects of antidepressants", section on 'Risk of switching to mania'</a>.)</p><p>The role of antidepressants in treating rapid cycling patients with major depression is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/16890.html" rel="external">"Rapid cycling bipolar disorder in adults: Treatment of major depression", section on 'Resistant patients'</a>.)</p><p class="headingAnchor" id="H5068116"><span class="h1">CLINICAL MANIFESTATION</span></p><p class="headingAnchor" id="H173673175"><span class="h2">Number of mood episodes</span><span class="headingEndMark"> — </span>The essential feature of rapid cycling is the occurrence of four or more bipolar mood episodes within a 12-month period [<a href="#rid2">2</a>]. The mood episodes consist of mania  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>), hypomania  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>), and major depression  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>); these mood episodes can occur in any combination and order. The episode symptoms that occur as part of a rapid cycling pattern are no different from those that occur as part of a non-rapid cycling pattern. However, the episodes may be of shorter duration, and the beginning and end of an episode may be more abrupt.</p><p>Separate mood episodes are demarcated from each other by either [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Switching from one pole to the other</p><p class="bulletIndent1"><span class="glyph">●</span>Full or partial remission for at least two months</p><p></p><p>Manic and hypomanic episodes are counted as being on the same pole; thus, a switch in polarity involves one of these episodes and an episode of major depression [<a href="#rid2">2</a>]. As an example, a patient with mania may remit and subsequently develop major depression. The time frame for switching poles is less than two months between the point that the patient has remitted from a mood episode on one pole and the point that the patient becomes ill with an episode on the other pole. In some cases, the switch occurs suddenly.</p><p>Although there is no established definition for partial remission, most authorities define it as stabilization of the patient’s safety and substantial improvement in the number, intensity, and frequency of psychotic and mood symptoms. Partial remission can be quantified with standardized rating scales that assess psychosis (eg, the Brief Psychiatric Rating Scale [<a href="#rid44">44</a>]), mania (eg, the Young Mania Rating Scale [<a href="#rid45">45</a>]), and depression (eg, the Patient Health Questionnaire – Nine Item  (<a class="graphic graphic_table graphicRef59307" href="/z/d/graphic/59307.html" rel="external">table 4</a>) [<a href="#rid46">46</a>]), but this is not standard clinical practice.</p><p>Most authorities think it is arbitrary to use a cut-off of four mood episodes to define rapid cycling bipolar disorder [<a href="#rid1">1,12,15,35,36,38,39</a>]. Although this cut-off was confirmed to some degree in studies that examined the validity of rapid cycling [<a href="#rid47">47-49</a>], subsequent studies that examined the stability, course of illness, and heritability of rapid cycling did not support this cut-off. In addition, the number of mood episodes observed in bipolar patients during a specific time period is distributed monotonically along a continuum [<a href="#rid12">12,15,18,39</a>]. Thus, rapid cycling appears to represent one extreme on the spectrum of episode frequency that occurs in bipolar disorder [<a href="#rid15">15,18</a>].</p><p class="headingAnchor" id="H173673501"><span class="h2">Duration</span><span class="headingEndMark"> — </span>Prospective studies indicate that rapid cycling bipolar disorder is generally a transient phenomenon (state) rather than a stable characteristic (trait) [<a href="#rid1">1,12,38</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A study of 356 bipolar patients with rapid cycling in the previous year found that during follow-up lasting 12 months, 91 percent converted to non-rapid cycling [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among 89 bipolar patients who developed rapid cycling during follow-up lasting a mean of 15 years, rapid cycling resolved within two years of onset in 78 percent of the patients and within three years in 92 percent [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of 58 rapid cycling bipolar patients followed for at least 12 months found that 53 percent converted to non-rapid cycling [<a href="#rid47">47</a>]</p><p></p><p>However, rapid cycling can persist for many years. In a prospective study that followed 109 rapid cycling bipolar patients for up to 36 years, the mean duration of rapid cycling was eight years [<a href="#rid50">50</a>]. One factor associated with persistent rapid cycling is a depression-(hypo)mania-interval course; the interval is characterized by full or partial remission. Other factors associated with worse outcomes include a sudden “switch” from depression to (hypo)mania, and the occurrence of agitated/mixed depressions.</p><p>The long-term course of illness in patients with rapid cycling is discussed elsewhere in this topic. (See <a class="local">'Course of illness'</a> below.)</p><p class="headingAnchor" id="H173673637"><span class="h2">Other features</span><span class="headingEndMark"> — </span>Rapid cycling can occur at any point in the bipolar patient’s course of illness. A review of four studies, which included 181 rapid cycling patients, found that rapid cycling was present at the onset of bipolar disorder in 27 percent [<a href="#rid10">10</a>]. A study of 109 bipolar patients with past-year rapid cycling found that onset of rapid cycling followed onset of bipolar disorder by a mean of 11 years [<a href="#rid50">50</a>]. In addition, case reports describe onset of rapid cycling in geriatric bipolar patients [<a href="#rid51">51,52</a>].</p><p>The sequence of mood episodes observed during rapid cycling varies greatly; a few examples include  (<a class="graphic graphic_figure graphicRef72619" href="/z/d/graphic/72619.html" rel="external">figure 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Individual mood episodes that are each followed by a period of euthymia</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Continuous cycling – Alternating episodes of opposite polarity (major depression on one pole and manic/hypomanic episodes on the other pole) with no intervening period of euthymia</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Numerous mood episodes that form no discernible pattern </p><p></p><p>The predominant psychopathology in rapid cycling bipolar disorder is generally depression, rather than mania or hypomania [<a href="#rid53">53</a>]. As an example, among 206 bipolar patients who suffered rapid cycling during prospective follow-up lasting for one year, depressive symptoms were present for twice as many days as were manic/hypomanic symptoms (145 versus 73 days) [<a href="#rid15">15</a>]. This is consistent with the finding that depression is the predominant mood state for bipolar patients in general [<a href="#rid54">54-56</a>].</p><p>Rapid cycling bipolar disorder often includes brief mood states or “truncated episodes” with manic, hypomanic, and/or depressive symptoms that meet DSM-5-TR symptom criteria but not duration criteria for a mood episode:</p><p class="bulletIndent1"><span class="glyph">●</span>A study prospectively followed 206 rapid cycling patients for 12 months and found that an average of nine truncated episodes occurred per year, in addition to full mood episodes [<a href="#rid15">15</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study prospectively followed 96 rapid cycling patients for at least 12 months and found that an average of four to eight truncated episodes occurred per year, in addition to full mood episodes [<a href="#rid47">47</a>] </p><p></p><p>However, it is difficult to distinguish multiple truncated episodes from a single episode with mixed features (concurrent symptoms of major depression and mania/hypomania) [<a href="#rid49">49</a>].</p><p>The frequency of rapid cycling in bipolar I and bipolar II disorder does not appear to differ substantially [<a href="#rid7">7</a>]. A cross-national community study found no difference in the 12-month prevalence of rapid cycling among individuals with bipolar I or bipolar II disorder [<a href="#rid5">5</a>]. Although a meta-analysis of 11 clinical studies (2686 bipolar patients) [<a href="#rid10">10</a>] and a subsequent study (1225 bipolar patients) [<a href="#rid11">11</a>] each found a history of rapid cycling in more bipolar II patients than bipolar I patients, another subsequent study (500 bipolar patients) found that the prevalence of rapid cycling in bipolar I patients and bipolar II patients was nearly identical [<a href="#rid13">13</a>], and yet another study (539 bipolar patients) found that the prevalence of rapid cycling was greater in bipolar I patients [<a href="#rid15">15</a>].</p><p>Several studies suggest that the frequency of psychosis in rapid cycling and non-rapid cycling bipolar patients does not differ [<a href="#rid13">13,15,47</a>]. As an example, the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study found that a lifetime history of psychotic mood episodes was roughly comparable in rapid cycling and non-rapid cycling patients (39 and 46 percent) [<a href="#rid13">13</a>]. However, other studies have found that psychotic features occurred more often in rapid cycling bipolar disorder than non-rapid cycling bipolar disorder [<a href="#rid8">8,9</a>].</p><p>The rate of attempted suicide in rapid cycling and non-rapid cycling bipolar disorder appears to be similar [<a href="#rid5">5</a>]. In a meta-analysis of six studies (1171 bipolar patients, including 454 with rapid cycling), a history of attempted suicide was found in a comparable number of rapid cycling and non-rapid cycling patients (35 versus 30 percent) [<a href="#rid10">10</a>]. Subsequently, a retrospective study of 128 patients with rapid cycling bipolar disorder and 1547 with non-rapid cycling bipolar disorder also found that a similar proportion had attempted suicide (8 and 7 percent) [<a href="#rid9">9</a>]. However, one study found that the mean lifetime number of suicide attempts was greater in rapid cycling patients (n = 159) than non-rapid cycling patients (n = 567; 1.0 versus 0.6) [<a href="#rid7">7</a>].</p><p>Hospitalization is more likely to occur in rapid-cycling bipolar disorder than non-rapid cycling bipolar disorder [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H4504928"><span class="h1">COMORBIDITY</span><span class="headingEndMark"> — </span>Comorbid psychiatric and general medical disorders are common in patients with rapid cycling bipolar disorder.</p><p>Rapid cycling bipolar patients are significantly more likely than non-rapid cycling patients to have a lifetime history of comorbid psychopathology, including [<a href="#rid5">5,7,15</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Anxiety disorders (eg, panic disorder, generalized anxiety disorder, social phobia, and specific phobia)</p><p class="bulletIndent1"><span class="glyph">●</span>Attention-deficit hyperactivity disorder</p><p class="bulletIndent1"><span class="glyph">●</span>Bulimia nervosa</p><p class="bulletIndent1"><span class="glyph">●</span>Obsessive-compulsive disorder</p><p class="bulletIndent1"><span class="glyph">●</span>Substance use disorders</p><p></p><p>In addition, impulsivity (evaluated by a rating scale) is greater in rapid cycling bipolar disorder than non-rapid cycling bipolar disorder [<a href="#rid57">57</a>].</p><p>Multiple general medical illnesses are frequently observed in patients with rapid cycling [<a href="#rid8">8</a>]; one study (N = 225) found that the mean number of medical comorbidities was 2.5 [<a href="#rid58">58</a>]. Organ systems that are commonly affected include respiratory, musculoskeletal, neurologic, endocrine/metabolic, and genitourinary [<a href="#rid7">7,59</a>]. As an example, rapid cycling may be associated with migraine headaches [<a href="#rid60">60</a>] and neurodevelopmental disorders [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H92694551"><span class="h1">COURSE OF ILLNESS</span><span class="headingEndMark"> — </span>In patients with bipolar disorder, rapid cycling is generally a transient phenomenon; however, some patients manifest rapid cycling for many consecutive years before it resolves [<a href="#rid12">12,50</a>]. Once rapid cycling resolves, the risk for a subsequent period of rapid cycling is not known. The persistence of rapid cycling is discussed separately. (See <a class="local">'Duration'</a> above.)</p><p>Bipolar patients who suffer rapid cycling at some point in their course of illness have a poorer long-term prognosis (with more lifetime affective morbidity), compared with non-rapid cycling patients [<a href="#rid15">15,32,48</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A cross-national community study found that the number of lifetime mood episodes was greater in rapid cycling than non-rapid cycling patients (103 versus 28 episodes), as was the number of lifetime years with at least one episode (15 versus 6 years) [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study prospectively followed 345 bipolar patients for a mean of 14 years, during which 89 developed rapid cycling at some point [<a href="#rid14">14</a>]. The number of weeks with depressive symptoms was greater in rapid cycling than non-rapid cycling patients (42 versus 30 percent of follow-up weeks).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study prospectively followed 37 rapid cycling and 74 non-rapid cycling bipolar patients for up to five years [<a href="#rid48">48</a>]. During each year of follow-up, the number of recurrent mood episodes was greater in the patients initially classified as rapid cyclers, even after rapid cycling resolved.</p><p></p><p>One form of rapid cycling is continuous cycling, which consists of alternating episodes of opposite polarity (major depression on one pole and manic/hypomanic episodes on the other pole) that are immediately contiguous with each other or separated by less than eight weeks of remission. These patients may have a poorer prognosis than rapid cycling patients with intermittent periods of euthymia and non-rapid cycling patients [<a href="#rid61">61</a>].</p><p>Bipolar patients who at one point experience rapid cycling may recover from bipolar disorder. In a study of 109 bipolar patients with rapid cycling who were followed prospectively for up to 36 years, 33 percent recovered (defined as no recurrent mood episodes for at least one year); the mean duration of recovery was 11 years [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H81537325"><span class="h1">ASSESSMENT</span><span class="headingEndMark"> — </span>The initial clinical evaluation of patients with a possible diagnosis of rapid cycling bipolar disorder includes a psychiatric and general medical history, mental status and physical examination, and focused laboratory tests [<a href="#rid62">62-64</a>]. The psychiatric history should emphasize the number of major depressive  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>), manic  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>), and hypomanic  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>) episodes during the previous 12 months (current rapid cycling), as well as any previous 12-month period (lifetime rapid cycling) [<a href="#rid2">2</a>]. Patients may have difficulty distinguishing past mood episodes when they are not separated by long intervals of euthymia; interviewing family members may help to determine the number and type of mood episodes that have occurred. The demarcation between separate mood episodes is discussed elsewhere in this topic. (See <a class="local">'Diagnosis'</a> below.)</p><p>No self-report instrument is available to screen for rapid cycling or assess response to treatment. Additional information about assessing bipolar patients in general is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/86602.html" rel="external">"Bipolar disorder in adults: Assessment and diagnosis", section on 'Assessment'</a>.)</p><p class="headingAnchor" id="H16495348"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H4191152061"><span class="h2">Overview</span><span class="headingEndMark"> — </span>According to DSM-5-TR, the essential feature of rapid cycling is the occurrence of four or more bipolar mood episodes within a 12-month period [<a href="#rid2">2</a>]. Thus, the term rapid cycling is used to specify the course of illness, rather than a subtype of bipolar disorder. The following subtypes of bipolar disorder may warrant a rapid cycling specifier:</p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar I disorder – Patients with bipolar I disorder experience manic episodes  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>), and nearly always experience hypomanic  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>) and major depressive episodes  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>). In addition, patients who only experience manic episodes (sometimes called “unipolar mania”) are also classified as bipolar I disorder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar II disorder – Bipolar II disorder is marked by at least one hypomanic episode, at least one major depressive episode, and the absence of manic episodes.</p><p></p><p>Any bipolar I or bipolar II patient can develop rapid cycling and then subsequently revert to a non-rapid cycling course [<a href="#rid36">36</a>]. (See <a class="local">'Duration'</a> above.)</p><p>Beyond bipolar I and bipolar II disorder, the rapid cycling specifier is not used to characterize the course of illness in other DSM-5-TR bipolar and related disorders [<a href="#rid2">2</a>].</p><p>Additional information about diagnosing each bipolar subtype is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/86602.html" rel="external">"Bipolar disorder in adults: Assessment and diagnosis", section on 'Bipolar disorders'</a>.)</p><p class="headingAnchor" id="H2119407454"><span class="h2">Rapid cycling</span><span class="headingEndMark"> — </span>According to DSM-5-TR, the diagnostic criteria for rapid cycling are as follows [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>At least four bipolar mood episodes in a 12-month period.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The episodes meet both the symptom and duration criteria for major depression  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>), mania  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>), or hypomania  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>); the episodes that occur as part of a rapid cycling pattern are no different from episodes that occur as part of a non-rapid cycling pattern. Mood episodes that are directly caused by substance intoxication (eg, cocaine or corticosteroids) or a general medical disorder do not count toward defining a rapid-cycling pattern.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The mood episodes can occur in any order or combination.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The episodes are demarcated by either:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A period of partial or full remission for at least two months, or</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A switch to an episode of opposite polarity. Manic and hypomanic episodes are counted as being on the same pole; thus, a switch in polarity involves one of these episodes and an episode of major depression. The time frame for switching poles is less than two months between the point that the patient has remitted from a mood episode on one pole and the point that the patient becomes ill with an episode on the other pole. In some cases the switch occurs suddenly.</p><p></p><p>Although the DSM-5-TR does not include a definition for partial remission, most authorities define it as stabilization of the patient’s safety and substantial improvement in the number, intensity, and frequency of psychotic and mood symptoms.</p><p>Patients who manifest brief mood states in the absence of full-duration mood episodes are classified as other specified bipolar disorder, without the additional course specifier rapid cycling. Rapid shifts between mood states have been described in case reports as “ultra-rapid cycling,” in which patients alternate between periods of mania/hypomania, depression, and euthymia, with each mood state lasting approximately 24 hours [<a href="#rid65">65,66</a>]. “Ultradian cycling” has also been described, consisting of shifts between different mood states (lasting only several hours), occurring within one day [<a href="#rid66">66,67</a>]. The mood states seen during ultra-rapid cycling and ultradian cycling do not meet duration criteria for mood episodes as defined in the DSM-5-TR [<a href="#rid2">2</a>]. If these brief mood states meeting symptom criteria but not duration criteria for mood episodes were counted along with full-duration episodes, more bipolar patients would be classified as rapid cyclers [<a href="#rid49">49</a>].</p><p>The World Health Organization's International Classification of Diseases-11<sup>th</sup> Revision (ICD-11), which has been harmonized with the DSM-5-TR, also includes a rapid cycling specifier for bipolar type I and II disorder [<a href="#rid68">68</a>].</p><p class="headingAnchor" id="H16496710"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The psychopathology of rapid cycling bipolar disorder overlaps with that of borderline personality disorder [<a href="#rid12">12,36</a>]. In addition, the two disorders often co-occur in the same patient [<a href="#rid69">69</a>].</p><p>The overlap between rapid cycling bipolar disorder and borderline personality disorder includes rapid switches between mood elevation (mania or hypomania) and major depression that can occur in rapid cycling; these switches may resemble the mood lability that occurs in borderline personality disorder [<a href="#rid12">12</a>]. However, the affective instability of borderline patients is generally a reaction to environmental triggers such as perceived rejection or failure, which is typically not the case in rapid cycling patients. In addition, borderline patients are characterized by episodic dysphoria, irritability, or anxiety, rather than mood elevation. Borderline personality disorder is also marked by unstable and intense interpersonal relationships, identity disturbance (unstable self-image or sense of self), chronic feelings of emptiness, and frantic efforts to avoid abandonment; these features are not characteristic of rapid cycling bipolar disorder [<a href="#rid2">2</a>].</p><p>Additional information about the differential diagnosis of bipolar disorder in general is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/86602.html" rel="external">"Bipolar disorder in adults: Assessment and diagnosis", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H13496906"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (See  <a class="medical medical_basics" href="/z/d/html/15348.html" rel="external">"Patient education: Bipolar disorder (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/16338.html" rel="external">"Patient education: Coping with high drug prices (The Basics)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (See  <a class="medical medical_patient" href="/z/d/html/4869.html" rel="external">"Patient education: Bipolar disorder (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/16279.html" rel="external">"Patient education: Coping with high prescription drug prices in the United States (Beyond the Basics)"</a>.)</p><p></p><p>These educational materials can be used as part of psychoeducational psychotherapy. (See  <a class="medical medical_review" href="/z/d/html/14666.html" rel="external">"Bipolar disorder in adults: Psychoeducation and other adjunctive maintenance psychotherapies", section on 'Group psychoeducation'</a>.)</p><p>The National Institute of Mental Health also has educational material explaining the symptoms, course of illness, and treatment of bipolar disorder in a booklet entitled "Bipolar Disorder," which is available online at <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.nimh.nih.gov%2Fhealth%2Fpublications%2Fbipolar-disorder&amp;token=c9TXCEotcdMcarRyXBEnhwgIEx3THC4PwSF2z%2FRKFh%2B8HmGSkeqm5bDBx4bOcfNh0qAPwOVFAtZ6twY6hM0vtq8AtSQsFLDSFqHlsS1NKKs%3D&amp;TOPIC_ID=15249" target="_blank">the website</a> or through a toll-free number, 866-615-6464. The web site also provides references, summaries of study results in language intended for the lay public, and information about clinical trials currently recruiting patients.</p><p>More comprehensive information is provided in many books written for patients and family members, including The Bipolar Disorder Survival Guide: What You and Your Family Need to Know, Third Edition, written by David J. Miklowitz, PhD (published by The Guilford Press, 2019); An Unquiet Mind: A Memoir of Moods and Madness, written by Kay Jamison, PhD (published by Random House, 1995); and Treatment of Bipolar Illness: A Casebook for Clinicians and Patients, by RM Post, MD, and GS Leverich, LCSW (published by Norton Press, 2008).</p><p>The Depression and Bipolar Support Alliance (accessible at <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.dbsalliance.org%2F&amp;token=ZAuWdG5s4GIvjFnkWRP6rC6dBWU8%2FMZEcwGeeAm5c58EpMgcvhu2s4%2FQc68YQejm&amp;TOPIC_ID=15249" target="_blank">the website</a> or 800-826-3632) is a national organization that educates members about bipolar disorder and how to cope with it. Other functions include increasing public awareness of the illness and advocating for more research and services. The organization is administered and maintained by patients and family members, and has local chapters.</p><p>The National Alliance on Mental Illness (accessible at <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.nami.org%2FHome&amp;token=wEsKVFvqlKzpT%2BqOtddW%2F8kABYN690CzsdrTBuRq2QekIBbQQeqX70Vmx%2B0z8d0m&amp;TOPIC_ID=15249" target="_blank">the website</a> or 800-950-6264) is a similarly structured organization devoted to education, support, and advocacy for patients with any mental illness. Bipolar disorder is one of their priorities.</p><p class="headingAnchor" id="H5068193"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar disorder is characterized by episodes of mania  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>), hypomania  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>), and major depression  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>). (See <a class="local">'Definitions'</a> above and  <a class="medical medical_review" href="/z/d/html/14642.html" rel="external">"Bipolar disorder in adults: Clinical features", section on 'Clinical presentation'</a> and  <a class="medical medical_review" href="/z/d/html/86602.html" rel="external">"Bipolar disorder in adults: Assessment and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rapid cycling bipolar disorder is diagnosed in patients with four or more mood episodes during a 12-month period. These episodes can occur in any order or combination, and are no different from episodes that occur as part of a non-rapid cycling pattern. Separate mood episodes are demarcated from each other either by a switch from one pole to the other (eg, major depression to mania), or by full or partial remission for at least two months. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The estimated 12-month prevalence of rapid cycling bipolar disorder in the general population is 0.3 percent. Among bipolar patients seen in clinical settings, approximately 16 to 17 percent have rapid cycling. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The pathogenesis of rapid cycling bipolar disorder is not known. Although some authorities maintain that antidepressants can trigger and prolong rapid cycling bipolar disorder, this is not established. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most authorities think it is arbitrary to use a cut-off of four mood episodes to define rapid cycling bipolar disorder, and conceptualize rapid cycling as one extreme on the spectrum of episode frequency that occurs in bipolar disorder. (See <a class="local">'Number of mood episodes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rapid cycling bipolar disorder is generally a transient phenomenon that can occur at any point in the bipolar patient’s course of illness. However, some patients in clinical settings may experience rapid cycling for many years. The sequence of mood episodes observed during rapid cycling varies greatly  (<a class="graphic graphic_figure graphicRef72619" href="/z/d/graphic/72619.html" rel="external">figure 1</a>), and the predominant psychopathology is generally depression. Rapid cycling patients are significantly more likely than non-rapid cycling patients to have a lifetime history of comorbid psychopathology. (See <a class="local">'Duration'</a> above and <a class="local">'Other features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar patients who suffer rapid cycling at some point in their course of illness have a poorer long-term course of illness, compared with non-rapid cycling patients. (See <a class="local">'Course of illness'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The initial clinical evaluation of patients with a possible diagnosis of rapid cycling bipolar disorder includes a psychiatric and general medical history, mental status and physical examination, and focused laboratory tests. The psychiatric history should emphasize the number of mood episodes during the previous 12 months, as well as any previous 12-month period. (See <a class="local">'Assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rapid cycling bipolar disorder needs to be distinguished from borderline personality disorder. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, Second Edition, Oxford University Press, Oxford 2007.</li><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), Washington, DC 2022.</li><li><a class="nounderline abstract_t">Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30:229.</a></li><li><a class="nounderline abstract_t">Tondo L, Hennen J, Baldessarini RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand 2003; 108:4.</a></li><li><a class="nounderline abstract_t">Lee S, Tsang A, Kessler RC, et al. Rapid-cycling bipolar disorder: cross-national community study. Br J Psychiatry 2010; 196:217.</a></li><li><a class="nounderline abstract_t">Carvalho AF, Dimellis D, Gonda X, et al. Rapid cycling in bipolar disorder: a systematic review. J Clin Psychiatry 2014; 75:e578.</a></li><li><a class="nounderline abstract_t">Antonietta Furio M, Popovic D, Vieta E, et al. Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE-II-MIX study. Bipolar Disord 2021; 23:391.</a></li><li><a class="nounderline abstract_t">Kato M, Adachi N, Kubota Y, et al. Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI). J Psychiatr Res 2020; 131:228.</a></li><li><a class="nounderline abstract_t">Buoli M, Cesana BM, Maina G, et al. Correlates of current rapid-cycling bipolar disorder: Results from the Italian multicentric RENDiBi study. Eur Psychiatry 2019; 62:82.</a></li><li><a class="nounderline abstract_t">Kupka RW, Luckenbaugh DA, Post RM, et al. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry 2003; 64:1483.</a></li><li><a class="nounderline abstract_t">Erol A, Winham SJ, McElroy SL, et al. Sex differences in the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I and II disorder. Bipolar Disord 2015; 17:670.</a></li><li><a class="nounderline abstract_t">Bauer M, Beaulieu S, Dunner DL, et al. Rapid cycling bipolar disorder--diagnostic concepts. Bipolar Disord 2008; 10:153.</a></li><li><a class="nounderline abstract_t">Schneck CD, Miklowitz DJ, Calabrese JR, et al. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry 2004; 161:1902.</a></li><li><a class="nounderline abstract_t">Coryell W, Solomon D, Turvey C, et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003; 60:914.</a></li><li><a class="nounderline abstract_t">Kupka RW, Luckenbaugh DA, Post RM, et al. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry 2005; 162:1273.</a></li><li><a class="nounderline abstract_t">McGuffin P, Rijsdijk F, Andrew M, et al. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003; 60:497.</a></li><li class="breakAll">Lohoff FW, Berrettini WH. Genetics of bipolar disorder. In: Bipolar Disorder: Clinical and Neurobiological Foundations, Yatham LN, Maj M (Eds), Wiley-Blackwell, West Sussex, UK 2010. p.110.</li><li><a class="nounderline abstract_t">Fisfalen ME, Schulze TG, DePaulo JR Jr, et al. Familial variation in episode frequency in bipolar affective disorder. Am J Psychiatry 2005; 162:1266.</a></li><li><a class="nounderline abstract_t">Kirov G, Murphy KC, Arranz MJ, et al. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol Psychiatry 1998; 3:342.</a></li><li><a class="nounderline abstract_t">Sjöholm LK, Backlund L, Cheteh EH, et al. CRY2 is associated with rapid cycling in bipolar disorder patients. PLoS One 2010; 5:e12632.</a></li><li><a class="nounderline abstract_t">Green EK, Raybould R, Macgregor S, et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry 2006; 188:21.</a></li><li><a class="nounderline abstract_t">Müller DJ, de Luca V, Sicard T, et al. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br J Psychiatry 2006; 189:317.</a></li><li><a class="nounderline abstract_t">Cusin C, Serretti A, Lattuada E, et al. Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders. J Psychiatr Res 2001; 35:217.</a></li><li><a class="nounderline abstract_t">Rousseva A, Henry C, van den Bulke D, et al. Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Pharmacogenomics J 2003; 3:101.</a></li><li><a class="nounderline abstract_t">Calkin CV, Ruzickova M, Uher R, et al. Insulin resistance and outcome in bipolar disorder. Br J Psychiatry 2015; 206:52.</a></li><li><a class="nounderline abstract_t">Buoli M, Serati M, Altamura AC. Biological aspects and candidate biomarkers for rapid-cycling in bipolar disorder: A systematic review. Psychiatry Res 2017; 258:565.</a></li><li><a class="nounderline abstract_t">Narita K, Suda M, Takei Y, et al. Volume reduction of ventromedial prefrontal cortex in bipolar II patients with rapid cycling: a voxel-based morphometric study. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:439.</a></li><li><a class="nounderline abstract_t">Blumberg HP, Krystal JH, Bansal R, et al. Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry 2006; 59:611.</a></li><li><a class="nounderline abstract_t">Agnew-Blais J, Danese A. Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry 2016; 3:342.</a></li><li><a class="nounderline abstract_t">Ghaemi SN. Treatment of rapid-cycling bipolar disorder: are antidepressants mood destabilizers? Am J Psychiatry 2008; 165:300.</a></li><li><a class="nounderline abstract_t">El-Mallakh RS, Vöhringer PA, Ostacher MM, et al. Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial. J Affect Disord 2015; 184:318.</a></li><li><a class="nounderline abstract_t">Coryell W. Rapid cycling bipolar disorder: clinical characteristics and treatment options. CNS Drugs 2005; 19:557.</a></li><li><a class="nounderline abstract_t">Bauer M, Rasgon N, Grof P, et al. Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder. Eur Psychiatry 2006; 21:262.</a></li><li><a class="nounderline abstract_t">Licht RW, Gijsman H, Nolen WA, Angst J. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr Scand 2008; 118:337.</a></li><li><a class="nounderline abstract_t">Goodwin GM, Haddad PM, Ferrier IN, et al. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2016; 30:495.</a></li><li class="breakAll">National Institute for Health and Care Excellence. Bipolar disorder: assessment and management. Clinical guideline [CG185]. February 11, 2020. https://www.nice.org.uk/guidance/cg185 (Accessed on December 22, 2020).</li><li><a class="nounderline abstract_t">Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013; 170:1249.</a></li><li><a class="nounderline abstract_t">Schneck CD, Miklowitz DJ, Miyahara S, et al. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry 2008; 165:370.</a></li><li><a class="nounderline abstract_t">Coryell W, Endicott J, Keller M. Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry 1992; 49:126.</a></li><li><a class="nounderline abstract_t">Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60:1079.</a></li><li><a class="nounderline abstract_t">Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356:1711.</a></li><li><a class="nounderline abstract_t">Ghaemi SN, Wingo AP, Filkowski MA, Baldessarini RJ. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand 2008; 118:347.</a></li><li><a class="nounderline abstract_t">Altshuler LL, Post RM, Hellemann G, et al. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J Clin Psychiatry 2009; 70:450.</a></li><li><a class="nounderline abstract_t">Rhoades HM, Overall JE. The semistructured BPRS interview and rating guide. Psychopharmacol Bull 1988; 24:101.</a></li><li><a class="nounderline abstract_t">Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429.</a></li><li><a class="nounderline abstract_t">Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606.</a></li><li><a class="nounderline abstract_t">Bauer MS, Calabrese J, Dunner DL, et al. Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 1994; 151:506.</a></li><li><a class="nounderline abstract_t">Maj M, Magliano L, Pirozzi R, et al. Validity of rapid cycling as a course specifier for bipolar disorder. Am J Psychiatry 1994; 151:1015.</a></li><li><a class="nounderline abstract_t">Maj M, Pirozzi R, Formicola AM, Tortorella A. Reliability and validity of four alternative definitions of rapid-cycling bipolar disorder. Am J Psychiatry 1999; 156:1421.</a></li><li><a class="nounderline abstract_t">Koukopoulos A, Sani G, Koukopoulos AE, et al. Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients. J Affect Disord 2003; 73:75.</a></li><li><a class="nounderline abstract_t">Schneider AL, Wilcox CS. Divalproate augmentation in lithium-resistant rapid cycling mania in four geriatric patients. J Affect Disord 1998; 47:201.</a></li><li><a class="nounderline abstract_t">Camus V, de Mendonça Lima CA, Antonioli D, Wertheimer J. Rapid-cycling affective disorder in the elderly: clinical subtype or specific course of manic-depressive illness? J Geriatr Psychiatry Neurol 1997; 10:105.</a></li><li><a class="nounderline abstract_t">Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2015; 49:1087.</a></li><li><a class="nounderline abstract_t">Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59:530.</a></li><li><a class="nounderline abstract_t">Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60:261.</a></li><li><a class="nounderline abstract_t">Kupka RW, Altshuler LL, Nolen WA, et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord 2007; 9:531.</a></li><li><a class="nounderline abstract_t">Etain B, Mathieu F, Liquet S, et al. Clinical features associated with trait-impulsiveness in euthymic bipolar disorder patients. J Affect Disord 2013; 144:240.</a></li><li><a class="nounderline abstract_t">Kemp DE, Gao K, Chan PK, et al. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord 2010; 12:404.</a></li><li><a class="nounderline abstract_t">Kemp DE, Gao K, Ganocy SJ, et al. Medical and substance use comorbidity in bipolar disorder. J Affect Disord 2009; 116:64.</a></li><li><a class="nounderline abstract_t">Gordon-Smith K, Forty L, Chan C, et al. Rapid cycling as a feature of bipolar disorder and comorbid migraine. J Affect Disord 2015; 175:320.</a></li><li><a class="nounderline abstract_t">Maj M, Pirozzi R, Magliano L, Bartoli L. The prognostic significance of "switching" in patients with bipolar disorder: a 10-year prospective follow-up study. Am J Psychiatry 2002; 159:1711.</a></li><li><a class="nounderline abstract_t">Work Group on Psychiatric Evaluation, American Psychiatric Association Steering Committee on Practice Guidlines. Psychiatric evaluation of adults. Second edition. American Psychiatric Association. Am J Psychiatry 2006; 163:3.</a></li><li class="breakAll">American Psychiatric Association Practice Guideline for the Psychiatric Evaluation of Adults, Second Edition, 2006. http://www.psych.org/MainMenu/PsychiatricPractice/PracticeGuidelines_1.aspx (Accessed on July 18, 2011).</li><li class="breakAll">Freudenreich O, Nejad SH, Francis A, Fricchione GL. Psychosis, mania, and catatonia. In: Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, Second Edition, Levenson JL (Ed), American Psychiatric Publishing, Washington, DC 2011. p.219.</li><li><a class="nounderline abstract_t">Alarcon RD. Rapid cycling affective disorders: a clinical review. Compr Psychiatry 1985; 26:522.</a></li><li><a class="nounderline abstract_t">Kramlinger KG, Post RM. Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry 1996; 168:314.</a></li><li><a class="nounderline abstract_t">Bürgy M. Successful treatment of ultradian or ultra-ultra-rapid cycling: a case report. J Affect Disord 2011; 133:655.</a></li><li class="breakAll">The ICD-11 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization. ICD-11 for Mortality and Morbidity Statistics. World Health Organization. Available at: https://icd.who.int/browse11/l-m/en (Accessed on January 04, 2023).</li><li><a class="nounderline abstract_t">Frías Á, Baltasar I, Birmaher B. Comorbidity between bipolar disorder and borderline personality disorder: Prevalence, explanatory theories, and clinical impact. J Affect Disord 2016; 202:210.</a></li></ol></div><div id="topicVersionRevision">Topic 15249 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, Second Edition, Oxford University Press, Oxford 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), Washington, DC 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4589148" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clinical factors in lithium carbonate prophylaxis failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12807371" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Rapid-cycling bipolar disorder: effects of long-term treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20194545" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Rapid-cycling bipolar disorder: cross-national community study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25004199" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Rapid cycling in bipolar disorder: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32959482" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE-II-MIX study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33022523" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31550582" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Correlates of current rapid-cycling bipolar disorder: Results from the Italian multicentric RENDiBi study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14728111" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26529373" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Sex differences in the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I and II disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18199234" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Rapid cycling bipolar disorder--diagnostic concepts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15465989" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12963673" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The long-term course of rapid-cycling bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15994709" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12742871" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The heritability of bipolar affective disorder and the genetic relationship to unipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12742871" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The heritability of bipolar affective disorder and the genetic relationship to unipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15994708" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Familial variation in episode frequency in bipolar affective disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9702744" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20856823" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : CRY2 is associated with rapid cycling in bipolar disorder patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16388065" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17012654" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11578639" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12746735" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25323142" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Insulin resistance and outcome in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28864122" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Biological aspects and candidate biomarkers for rapid-cycling in bipolar disorder: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21115089" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Volume reduction of ventromedial prefrontal cortex in bipolar II patients with rapid cycling: a voxel-based morphometric study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16414030" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26873185" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18316425" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Treatment of rapid-cycling bipolar disorder: are antidepressants mood destabilizers?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26142612" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15984894" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Rapid cycling bipolar disorder: clinical characteristics and treatment options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16782312" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18754834" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26979387" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26979387" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24030475" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18198271" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1550465" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14609883" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17392295" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Effectiveness of adjunctive antidepressant treatment for bipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18727689" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19358785" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3290934" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The semistructured BPRS interview and rating guide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/728692" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : A rating scale for mania: reliability, validity and sensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11556941" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The PHQ-9: validity of a brief depression severity measure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8147448" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8010357" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Validity of rapid cycling as a course specifier for bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10484955" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Reliability and validity of four alternative definitions of rapid-cycling bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12507740" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9476762" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Divalproate augmentation in lithium-resistant rapid cycling mania in four geriatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9322132" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Rapid-cycling affective disorder in the elderly: clinical subtype or specific course of manic-depressive illness?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26643054" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12044195" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The long-term natural history of the weekly symptomatic status of bipolar I disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12622659" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17680925" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22901401" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Clinical features associated with trait-impulsiveness in euthymic bipolar disorder patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20636638" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19100627" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Medical and substance use comorbidity in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25661398" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Rapid cycling as a feature of bipolar disorder and comorbid migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12359677" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The prognostic significance of "switching" in patients with bipolar disorder: a 10-year prospective follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16866240" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Psychiatric evaluation of adults. Second edition. American Psychiatric Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16866240" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Psychiatric evaluation of adults. Second edition. American Psychiatric Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16866240" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Psychiatric evaluation of adults. Second edition. American Psychiatric Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2866063" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Rapid cycling affective disorders: a clinical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833685" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Ultra-rapid and ultradian cycling in bipolar affective illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21719109" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Successful treatment of ultradian or ultra-ultra-rapid cycling: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21719109" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Successful treatment of ultradian or ultra-ultra-rapid cycling: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27267293" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Comorbidity between bipolar disorder and borderline personality disorder: Prevalence, explanatory theories, and clinical impact.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
